Clinical Trial Update: A Study for HSK44459 in Participants With Atopic Dermatitis [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of HSK44459 for atopic dermatitis, with the trial currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• HSK44459

Snippet

Sponsor: Xizang Haisco Pharmaceutical Co., Ltd | Conditions: Atopic Dermatitis (AD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING